These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7867870)

  • 1. Influence of dietary composition on the inhibition of fat absorption by orlistat.
    Güzelhan C; Odink J; Niestijl Jansen-Zuidema JJ; Hartmann D
    J Int Med Res; 1994; 22(5):255-65. PubMed ID: 7867870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on dietary fat absorption of orlistat, administered at different times relative to meal intake.
    Hartmann D; Hussain Y; Güzelhan C; Odink J
    Br J Clin Pharmacol; 1993 Sep; 36(3):266-70. PubMed ID: 9114915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat.
    Hussain Y; Güzelhan C; Odink J; van der Beek EJ; Hartmann D
    J Clin Pharmacol; 1994 Nov; 34(11):1121-5. PubMed ID: 7876405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers.
    Melia AT; Zhi J; Zelasko R; Hartmann D; Güzelhan C; Guerciolini R; Odink J
    Eur J Clin Pharmacol; 1998; 54(9-10):773-7. PubMed ID: 9923583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.
    Bryson A; de la Motte S; Dunk C
    Br J Clin Pharmacol; 2009 Mar; 67(3):309-15. PubMed ID: 19220279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.
    Di Marco M; Marier JF; Ducharme MP; Morin I; Engel C; Gulbranson S; Thudi NR; Murpani D; Rampal A; Monif T; Koundinya TS; Deo K; Monif T
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):319-26. PubMed ID: 18541129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of fecal fat excretion induced by orlistat and chitosan.
    Guerciolini R; Radu-Radulescu L; Boldrin M; Dallas J; Moore R
    Obes Res; 2001 Jun; 9(6):364-7. PubMed ID: 11399783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers.
    Melia AT; Zhi J; Koss-Twardy SG; Min BH; Smith BL; Freundlich NL; Arora S; Passe SM
    J Clin Pharmacol; 1995 Aug; 35(8):840-3. PubMed ID: 8522642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
    Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
    Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of orlistat.
    Guerciolini R
    Int J Obes Relat Metab Disord; 1997 Jun; 21 Suppl 3():S12-23. PubMed ID: 9225172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects.
    O'Donovan D; Feinle-Bisset C; Wishart J; Horowitz M
    Br J Nutr; 2003 Nov; 90(5):849-52. PubMed ID: 14667178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium and calcium absorption in Fischer-344 rats influenced by changes in dietary fibre (wheat bran), fat and calcium.
    Watkins DW; Jahangeer S; Floor MK; Alabaster O
    Magnes Res; 1992 Mar; 5(1):15-21. PubMed ID: 1317206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipase inhibitor orlistat decreases incorporation of eicosapentaenoic and docosahexaenoic acids in rat tissues.
    Cruz-Hernandez C; Oliveira M; Pescia G; Moulin J; Masserey-Elmelegy I; Dionisi F; Destaillats F
    Nutr Res; 2010 Feb; 30(2):134-40. PubMed ID: 20226999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers.
    Zhi J; Melia AT; Koss-Twardy SG; Arora S; Patel IH
    J Clin Pharmacol; 1996 Feb; 36(2):152-9. PubMed ID: 8852391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of short-term (21-day) orlistat treatment on the physiologic balance of six selected macrominerals and microminerals in obese adolescents.
    Zhi J; Moore R; Kanitra L
    J Am Coll Nutr; 2003 Oct; 22(5):357-62. PubMed ID: 14559927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psyllium husk fibre supplementation to soybean and coconut oil diets of humans: effect on fat digestibility and faecal fatty acid excretion.
    Ganji V; Kies CV
    Eur J Clin Nutr; 1994 Aug; 48(8):595-7. PubMed ID: 7957006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipase inhibition and hormonal status, body composition and gastrointestinal processing of a liquid high-fat mixed meal in moderately obese subjects.
    Drent ML; Popp-Snijders C; Adèr HJ; Jansen JB; van der Veen EA
    Obes Res; 1995 Nov; 3(6):573-81. PubMed ID: 8653534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers.
    Zhi J; Melia AT; Guerciolini R; Chung J; Kinberg J; Hauptman JB; Patel IH
    Clin Pharmacol Ther; 1994 Jul; 56(1):82-5. PubMed ID: 8033498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the lipase inhibitor orlistat and of dietary lipid on the absorption of radiolabelled triolein, tri-gamma-linolenin and tripalmitin in mice.
    Isler D; Moeglen C; Gains N; Meier MK
    Br J Nutr; 1995 Jun; 73(6):851-62. PubMed ID: 7632666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat inhibits dietary cholesterol absorption.
    Mittendorfer B; Ostlund RE; Patterson BW; Klein S
    Obes Res; 2001 Oct; 9(10):599-604. PubMed ID: 11595776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.